Prime Medicine Capital Expenditures (CapEx) Growth & History (PRME)

Prime Medicine's capital expenditures (capex) was $4.5M for fiscal 2025.

View full Prime Medicine company overview

Prime Medicine annual capital expenditures (capex) history

Prime Medicine annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$4.5M−$2.8M−37.88%
20242024-12-31$7.3M−$1.4M−16.39%
20232023-12-31$8.7M−$7.4M−45.80%
20222022-12-31$16.1M$11.9M+287.83%
20212021-12-31$4.2M$3.5M+549.45%
20202020-12-31$639,000

Prime Medicine capital expenditures (capex) trends

Over the last five fiscal years, Prime Medicine's capital expenditures (capex) increased from $639,000 to $4.5M, a change of $3.9M. The latest reported quarter, Q2 2026, shows $46,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Prime Medicine source filings ↗

Community posts

It’s quiet here.

No posts about PRME yet. Start the conversation.

Write the first post